Jessica Federer
Strategic Advisor to The WHAM Investment Collaborative; Chair NYSE Health of Women Investor Summit; Former Bayer Chief Digital OfficerJessica Federer is a global leader in digital health and biotechnology. She serves on both publicly listed and private company boards, including Sage Therapeutics and Aspivix in women’s health. She is a board member of Angelini Ventures, which also invests in women’s health. Previously, Jessica was the Chief Digital Officer for Bayer AG, and held leadership roles across the global life sciences company.
She sits on the Yale Ventures Blavatnik board and Yale IRB, and chairs the NYSE Women’s Health Investor Summit, convening diverse investors to accelerate progress. She recently received the Rock Health “Icon” award for using technology to advance equity and impact. Federer is a well-known leader at the intersection of investment, technology and life sciences.
She sits on the Yale Ventures Blavatnik board and Yale IRB, and chairs the NYSE Women’s Health Investor Summit, convening diverse investors to accelerate progress. She recently received the Rock Health “Icon” award for using technology to advance equity and impact. Federer is a well-known leader at the intersection of investment, technology and life sciences.
